Clinical Genitourinary Cancer

投稿咨询

官方网站：http://www.journals.elsevier.com/clinical-genitourinary-cancer/

投稿网址：http://ees.elsevier.com/cguc/default.asp?acw=3

PMC链接：http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1558-7673%5BISSN%5D

《临床泌尿生殖癌》是世界上首屈一指的同行评审的，专门针对肿瘤的临床肿瘤杂志，专门发表临床相关的关于前列腺癌、尿癌和肾癌的检测、诊断、预防和治疗的文章。索引在index medicus/medline/pubmed、isi（当前内容/临床医学、科学引文索引扩展（科学网）、期刊引文报告）、embase、cinahl和化学文摘中。每一期的临床泌尿生殖系统癌症都有同行评审的原始贡献，邀请全面的评论，以及当前的治疗报告，以及每年主要肿瘤学会议的“会议要点”报告。同时也包括了最新新闻的简要社论，以及为临床医生提供的有关泌尿生殖系统癌症的最新话题。《临床泌尿生殖癌》是一本同行评议的杂志，发表了描述泌尿生殖癌临床和转化研究各个方面的原创文章。临床泌尿生殖癌是专门的文章检测、诊断、预防和治疗泌尿生殖癌。重点是与泌尿生殖系统恶性肿瘤有关的所有领域的最新科学发展。具体的关注领域包括临床研究和机械方法；药物敏感性和耐药性；基因和反义治疗；病理学、标志物和预后指标；化学预防策略；多模式治疗；以及各种方法的整合。

Clinical Genitourinary Cancer is the world’s premier peer-reviewed, tumor-specific, clinical oncology journal devoted to publishing clinically relevant articles on detection, diagnosis, prevention, and treatment of prostate, urinary, and renal cancers. Indexed in Index Medicus/Medline/Pubmed, ISI (Current Contents/Clinical Medicine, Science Citation Index Expanded (Web of Science), Journal Citation Reports), EMBASE, CINAHL, and Chemical Abstracts. Each issue of Clinical Genitourinary Cancer features peer-reviewed original contributions, invited comprehensive reviews, and current treatment reports, as well as "Meeting Highlights" reports taken from major oncology meetings each year. Also included are brief editorials of current news and the latest topics concerning genitourinary cancer for the clinician.Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.